News

December 11, 2007 - The FDA issued its final assessment of two long-term studies in patients with severe gastroesophageal reflux disease (GERD) who were being treated with either Prilosec or Nexium, and finds that “long-term use of these drugs is not likely to be associated with increased risk of heart problems.”

Home December 10, 2007
Home
News

December 11, 2007 ― GE partnered with anesthesiologists, emergency medicine physicians and other fields of medicine to ...

Home December 10, 2007
Home
News

December 11, 2007 – Due to the loss of more than 50 percent of the North American Mo-99 supply and its impact on the ...

Home December 10, 2007
Home
News

December 11, 2007 - GE’s SnapShot Pulse technology for prospectively gated diagnostic cardiac CT exams has been proven ...

Home December 10, 2007
Home
News

December 10, 2007 - Cardica Inc. announced that leading cardiac surgeons from The Heart Hospital Baylor Plano and ...

Home December 09, 2007
Home
News

December, 10, 2007 - Cardica Inc. today announced that leading cardiac surgeons from The Heart Hospital Baylor Plano and Centennial Medical Center in Nashville will webcast a live off-pump coronary artery bypass graft (CABG) procedure as well as a port-access robotic CABG procedure using innovative anastomotic devices from Cardica Inc. on Jan. 17, 2008.

Home December 09, 2007
Home
News

December 10, 2007 – Ymed Inc. announced that it has successfully completed its first U.S. cases with its proprietary ...

Home December 09, 2007
Home
News

December 10, 2007 - U.S. Secretary of Health and Human Services Michael Leavitt urged Congress Dec. 4 to include a ...

Home December 09, 2007
Home
News

December 7, 2007 — GE Healthcare has licensed a technique patented by an Eastern Virginia Medical School (EVMS) ...

Home December 06, 2007
Home
News

December 7, 2007 – The Siemens “Win an MRI" contest has closed and the polls are now open to award a MAGNETOM Essenza ...

Home December 06, 2007
Home
News

December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.

Home December 06, 2007
Home
News

December 7, 2007 - Cardinal Health and HemCon Medical Technologies Inc. this week announced the availability of co ...

Home December 06, 2007
Home
News

December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...

Home December 05, 2007
Home
News

December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...

Home December 05, 2007
Home
News

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...

Home December 05, 2007
Home
Subscribe Now